As of November 2024, Anixa Biosciences has a market cap of $105.64M. This makes Anixa Biosciences the world's 20947th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $125.83M | 4.38% |
2023 | $120.55M | -8.71% |
2022 | $132.05M | 43.10% |
2021 | $92.28M | -3.26% |
2020 | $95.38M | -6.40% |
2019 | $101.91M | -16.75% |
2018 | $122.42M | 66.95% |
2017 | $73.33M | -56.30% |
2016 | $167.78M | 79.40% |
2015 | $93.52M | 9.45% |
2014 | $85.44M | -42.11% |
2013 | $147.58M | 5.56% |
2012 | $139.81M | 63.64% |
2011 | $85.44M | -47.62% |
2010 | $163.12M | -67.19% |
2009 | $497.12M | 48.84% |
2008 | $334.00M | -70.34% |
2007 | $1.13B | 49.48% |
2006 | $753.45M | 22.78% |
2005 | $613.63M | -7.06% |
2004 | $660.24M | 84.78% |
2003 | $357.31M | 142.11% |
2002 | $147.58M | -55.81% |
2001 | $334.00M | -37.45% |
2000 | $534.02M | -15.38% |
1999 | $631.11M | -36.59% |
1998 | $995.21M | -63.39% |
1997 | $2.72B | -29.11% |
1996 | $3.84B | 2.60% |
1995 | $3.74B | 52.48% |
1994 | $2.45B | -51.44% |
1993 | $5.05B | 6.12% |
1992 | $4.76B | 2.08% |
1991 | $4.66B | 115.73% |
1990 | $2.16B | -19.09% |
1989 | $2.67B | -4.35% |
1988 | $2.79B | 79.69% |
1987 | $1.55B | -13.04% |
1986 | $1.79B | -23.33% |
1985 | $2.33B | 74.76% |
1984 | $1.33B | -17.60% |
1983 | $1.62B | - |